UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan

The Lancet (British edition), 2000-11, Vol.356 (9241), p.1565-1569

2000

Volltextzugriff (PDF)

Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran

Bulletin of the World Health Organization, 2003-01, Vol.81 (5), p.353-359

2003

Volltextzugriff (PDF)

Vervet Monkeys Vaccinated with Killed Leishmania major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection

Infection and Immunity, 2001-01, Vol.69 (1), p.245-251

2001

Volltextzugriff (PDF)

Dichotomy of protective cellular immune responses to human visceral leishmaniasis

Clinical and experimental immunology, 2005-05, Vol.140 (2), p.349-353

2005

Volltextzugriff (PDF)

Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG

Clinical and experimental immunology, 2003-11, Vol.134 (2), p.303-308

2003

Volltextzugriff (PDF)

Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis

Vaccine, 2005-05, Vol.23 (28), p.3642-3648

2005

Volltextzugriff (PDF)

Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2003-05, Vol.97 (3), p.365-368

2003

Volltextzugriff (PDF)

Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis

The American journal of tropical medicine and hygiene, 2012-07, Vol.87 (1), p.70-75

2012

Volltextzugriff (PDF)

Immunization with a Polyprotein Vaccine Consisting of the T-Cell Antigens Thiol-Specific Antioxidant, Leishmania major Stress-Inducible Protein 1, and Leishmania Elongation Initiation Factor Protects against Leishmaniasis

Infection and Immunity, 2002-08, Vol.70 (8), p.4215-4225

2002

Volltextzugriff (PDF)

Immunotherapy for Drug-Refractory Mucosal Leishmaniasis

The Journal of infectious diseases, 2006-10, Vol.194 (8), p.1151-1159

2006

Volltextzugriff (PDF)

Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2005-08, Vol.99 (8), p.593-598

2005

Volltextzugriff (PDF)

Vaccines against leishmaniasis

Annals of tropical medicine and parasitology, 1995-12, Vol.89 (sup1), p.83-88

Modabber, F.

1995

Volltextzugriff (PDF)

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran

The Lancet (British edition), 1998-05, Vol.351 (9115), p.1540-1543

1998

Volltextzugriff (PDF)

Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited

Vaccine, 2006-11, Vol.24 (47), p.6944-6954

2006

Volltextzugriff (PDF)

Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006

Kinetoplastid biology and disease, 2007-04, Vol.6 (3), p.3-3, Article 3

2007

Volltextzugriff (PDF)

Increased myelopoiesis during Leishmania major infection in mice: generation of safe targets, a possible way to evade the effector immune mechanism

Clinical and experimental immunology, 1986-04, Vol.64 (1), p.1-7

1986

Volltextzugriff (PDF)

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

Vaccine, 1999-02, Vol.17 (5), p.466-472

1999

Volltextzugriff (PDF)

Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study

Annals of tropical paediatrics, 2006-12, Vol.26 (4), p.357-361

2006

Volltextzugriff (PDF)

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial

International journal of dermatology, 2002-02, Vol.41 (2), p.73-78

2002

Volltextzugriff (PDF)

Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial

Annals of internal medicine, 1997-02, Vol.126 (3), p.232

1997

Volltextzugriff (PDF)

Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major

Infection and Immunity, 1979-11, Vol.26 (2), p.611-614

1979

Volltextzugriff (PDF)

Vaccines against leishmaniases: where we are and how far we have to go

Parasitology international, 1998-08, Vol.47, p.36-36

Modabber, F.

1998

Volltextzugriff (PDF)

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

Parasitology, 1989, Vol.98 Suppl (S1), p.S49-S60

Modabber, F

1989

Volltextzugriff (PDF)

The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis

Vaccine, 2002-12, Vol.21 (3), p.174-180

2002

Volltextzugriff (PDF)

A model for the mechanism of sensitivity of BALB/c mice to L. major and premunition in leishmaniases

Annales de l'Institut Pasteur. Immunology, 1987, Vol.138 (5), p.781-786

Modabber, F.

1987

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(129)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan

Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran

Vervet Monkeys Vaccinated with Killed Leishmania major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection

Dichotomy of protective cellular immune responses to human visceral leishmaniasis

Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG

Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis

Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers

Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis

Immunization with a Polyprotein Vaccine Consisting of the T-Cell Antigens Thiol-Specific Antioxidant, Leishmania major Stress-Inducible Protein 1, and Leishmania Elongation Initiation Factor Protects against Leishmaniasis

Immunotherapy for Drug-Refractory Mucosal Leishmaniasis

Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia

Vaccines against leishmaniasis

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran

Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited

Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006

Increased myelopoiesis during Leishmania major infection in mice: generation of safe targets, a possible way to evade the effector immune mechanism

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial

Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial

Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major

Vaccines against leishmaniases: where we are and how far we have to go

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis

A model for the mechanism of sensitivity of BALB/c mice to L. major and premunition in leishmaniases

Suchergebnisse filtern